Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
764.00    -4.00 (-0.52%)
Bid:
763.00
Ask:
764.50
Spread: 1.50 (0.197%)
Market Cap: £1.54b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Transaction in Own Shares

26 Feb 2025 07:00

RNS Number : 4252Y
Dunelm Group plc
26 February 2025
 

26 February 2025

 

DUNELM GROUP PLC

Transaction in own shares

 

 

Dunelm Group plc (the "Company") announces that on 25 February 2025 it purchased the following number of ordinary shares of 1 pence each in the Company pursuant to its share buyback programme, details of which were announced on 19 February 2025:

 

Date of purchase

25 February 2025

Number of ordinary shares purchased:

74,190

Highest price paid per share (p):

987.0

Lowest price paid per share (p):

980.0

Volume weighted average price paid (p):

983.91

Broker:

Peel Hunt LLP

 

The purchased shares will be held in treasury and may be utilised to satisfy employee share-based award obligations.

 

Following the purchase of these shares, the Company's issued ordinary share capital consists of 203,426,835 ordinary shares of which a total of 1,137,049 shares are held in treasury, including shares which have been purchased but not yet settled. Therefore, the total number of ordinary shares with voting rights in the Company is 202,289,786 ordinary shares.

 

The above figure of 202,289,786 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a detailed breakdown of individual trades made by Peel Hunt on behalf of the Company is detailed below:

 

Schedule of purchases - Individual transactions

 

Number of shares purchased

Transaction price (p)

Venue

Time of transaction

Trade ID

Dealt Ccy

10,000

981.0

XLON

Tue Feb 25 09:46:27 GMT 2025

00173394629TRLO0-1

GBP

10,000

980.0

XLON

Tue Feb 25 09:57:49 GMT 2025

00173395777TRLO0-1

GBP

10,000

982.5

XLON

Tue Feb 25 13:38:15 GMT 2025

00173410821TRLO0-1

GBP

10,000

982.5

XLON

Tue Feb 25 13:41:49 GMT 2025

00173411057TRLO0-1

GBP

15,000

987.0

XLON

Tue Feb 25 14:44:58 GMT 2025

00173419109TRLO0-1

GBP

19,190

986.5

XLON

Tue Feb 25 14:57:38 GMT 2025

00173421778TRLO0-1

GBP

 

 

For further information please contact:

 

Dunelm Group plc

 

Luisa Wright, Company Secretary investorrelations@dunelm.com

 

MHP Communications

 

Rachel Farrington/Charles Hirst dunelm@mhpgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSUVANRVRUUUAR
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
12th May 20267:00 amRNSDirector/PDMR Shareholding
8th May 20263:27 pmRNSDirector/PDMR Shareholding - Replacement
8th May 202611:00 amRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTotal Voting Rights
16th Apr 20267:00 amRNSThird quarter trading update
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSDirector/PDMR Shareholding
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20263:24 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSPurchases of Shares During Open Periods
13th Feb 202611:00 amRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSInterim Results
2nd Feb 20267:00 amRNSTotal Voting Rights
15th Jan 20267:00 amRNSSecond quarter and first half trading update
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
9th Dec 20257:00 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSPDMR Shareholding
28th Nov 20257:00 amRNSTotal Voting Rights
25th Nov 202510:14 amRNSDirector/PDMR Shareholding Amendment
25th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20252:30 pmRNSResult of AGM
11th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
31st Oct 20259:52 amRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTotal Voting Rights
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSFirst quarter trading statement
9th Oct 202510:00 amRNSNotice of AGM, Annual Report and Accounts
8th Oct 20257:00 amRNSBlock Listing Six Monthly Return
2nd Oct 20257:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.